semaglutide risk factors causing heartburn GLP-1 medications like and tirzepatide are on the rise, but so are Semaglutide Lowers Cardiovascular Risks But

Some studies have also demonstrated the neuroprotective effect of GLP-1RAs through broader mechanisms

Reckeweg is represented in more than 40 countries

Semaglutide has been studied for weight management, type 2 diabetes, and cardiovascular risk reduction in certain patients

Abdominal pain Headache Low blood sugar Constipation Fatigue Nausea Vomiting Diarrhea Dizziness Acid Reflux For the majority of individuals, symptoms tend to be mild and resolve spontaneously over time

By using AI to analyze more than 400,000 Reddit posts, Penn researchers have identified patient-reported symptoms associated with GLP-1s, the popular weight-loss and diabetes drugs semaglutide and tirzepatide, that may not be fully captured in clinical trials or regulatory documents